{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:45:10Z","timestamp":1790646310142,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"7-8","license":[{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,20]],"date-time":"2014-11-20T00:00:00Z","timestamp":1416441600000},"content-version":"vor","delay-in-days":1603,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["NS045806"],"award-info":[{"award-number":["NS045806"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["U01AT000613"],"award-info":[{"award-number":["U01AT000613"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["NS058793"],"award-info":[{"award-number":["NS058793"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1016\/j.bbadis.2010.05.001","type":"journal-article","created":{"date-parts":[[2010,5,11]],"date-time":"2010-05-11T07:44:44Z","timestamp":1273563884000},"page":"673-681","source":"Crossref","is-referenced-by-count":37,"title":["Reduced creatine kinase as a central and peripheral biomarker in Huntington's disease"],"prefix":"10.1016","volume":"1802","author":[{"given":"Jinho","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Amante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer P.","family":"Moody","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina K.","family":"Edgerly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia L.","family":"Bordiuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha A.","family":"Matson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne R.","family":"Matson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clemens R.","family":"Scherzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Diana","family":"Rosas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven M.","family":"Hersch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Ferrante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2010.05.001_bib1","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1517\/13543784.16.12.1933","article-title":"Huntington's disease: progress and potential in the field","volume":"16","author":"Stack","year":"2007","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.bbadis.2010.05.001_bib2","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1111\/j.1471-4159.1985.tb07192.x","article-title":"Regional mitochondrial respiratory activity in Huntington's disease brain","volume":"44","author":"Brennan","year":"1985","journal-title":"J Neurochem"},{"key":"10.1016\/j.bbadis.2010.05.001_bib3","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1212\/WNL.40.8.1231","article-title":"Evidence for a defect in NADH: ubiquinone oxidoreductase (complex I) in Huntington's disease","volume":"40","author":"Parker","year":"1990","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2010.05.001_bib4","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/0140-6736(90)92242-A","article-title":"Mitochondrial function and parental sex effect in Huntington's disease","volume":"336","author":"Mann","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.bbadis.2010.05.001_bib5","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1023\/B:NERE.0000014824.04728.dd","article-title":"The energetics of Huntington's disease","volume":"29","author":"Browne","year":"2004","journal-title":"Neurochem Res"},{"key":"10.1016\/j.bbadis.2010.05.001_bib6","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/ana.410390317","article-title":"Mitochondrial defect in Huntington's disease caudate nucleus","volume":"39","author":"Gu","year":"1996","journal-title":"Ann Neurol"},{"key":"10.1016\/j.bbadis.2010.05.001_bib7","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nn884","article-title":"Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines","volume":"5","author":"Panov","year":"2002","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.bbadis.2010.05.001_bib8","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1212\/WNL.42.4.733","article-title":"Alternative excitotoxic hypotheses","volume":"42","author":"Albin","year":"1992","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2010.05.001_bib9","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1212\/01.WNL.0000031791.10922.CF","article-title":"Weight loss in early stage of Huntington's disease","volume":"59","author":"Djousse","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2010.05.001_bib10","first-page":"199","article-title":"Local cerebral glucose utilization in symptomatic and presymptomatic Huntington's disease","volume":"63","author":"Kuhl","year":"1985","journal-title":"Res Publ Assoc Res Nerv Ment Dis"},{"issue":"Pt 5","key":"10.1016\/j.bbadis.2010.05.001_bib11","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1093\/brain\/113.5.1405","article-title":"Cortical and subcortical glucose consumption measured by PET in patients with Huntington's disease","volume":"113","author":"Kuwert","year":"1990","journal-title":"Brain"},{"key":"10.1016\/j.bbadis.2010.05.001_bib12","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/ana.410410206","article-title":"Energy metabolism defects in Huntington's disease and effects of coenzyme Q10","volume":"41","author":"Koroshetz","year":"1997","journal-title":"Ann Neurol"},{"key":"10.1016\/j.bbadis.2010.05.001_bib13","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1006\/neur.1996.0004","article-title":"Immunoreactive levels of alpha-ketoglutarate dehydrogenase subunits in Friedreich's ataxia and spinocerebellar ataxia type 1","volume":"5","author":"Mastrogiacomo","year":"1996","journal-title":"Neurodegeneration"},{"key":"10.1016\/j.bbadis.2010.05.001_bib14","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1600-0404.1996.tb00174.x","article-title":"Elevated cerebrospinal fluid lactate\/pyruvate ratio in Machado\u2013Joseph disease","volume":"93","author":"Matsuishi","year":"1996","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.bbadis.2010.05.001_bib15","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.bbadis.2009.04.001","article-title":"Mouse models of Huntington's disease and methodological considerations for therapeutic trials","volume":"1792","author":"Ferrante","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.bbadis.2010.05.001_bib16","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/978-1-4020-6486-9_2","article-title":"Early evolution of the creatine kinase gene family and the capacity for creatine biosynthesis and membrane transport","volume":"46","author":"Ellington","year":"2007","journal-title":"Subcell Biochem"},{"key":"10.1016\/j.bbadis.2010.05.001_bib17","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/0006-291X(65)90200-7","article-title":"Creatine kinase: evidence for a dimeric structure","volume":"21","author":"Dawson","year":"1965","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bbadis.2010.05.001_bib18","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1742-7843.2009.00406.x","article-title":"Oxidative stress alters creatine kinase system in serum and brain regions of polychlorinated biphenyl (Aroclor 1254)-exposed rats: protective role of melatonin","volume":"105","author":"Venkataraman","year":"2009","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.bbadis.2010.05.001_bib19","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1196\/annals.1427.008","article-title":"Evidence of oxidant damage in Huntington's disease: translational strategies using antioxidants","volume":"1147","author":"Stack","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.bbadis.2010.05.001_bib20","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1460-9568.2004.03478.x","article-title":"Distinct cellular expressions of creatine synthetic enzyme GAMT and creatine kinases uCK-Mi and CK-B suggest a novel neuron-glial relationship for brain energy homeostasis","volume":"20","author":"Tachikawa","year":"2004","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.bbadis.2010.05.001_bib21","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/0166-2236(87)90120-2","article-title":"Patterns of cell loss in Huntington's disease","volume":"10","author":"Kowall","year":"1987","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.bbadis.2010.05.001_bib22","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1074\/mcp.M500090-MCP200","article-title":"Proteomic analysis of protein expression and oxidative modification in r6\/2 transgenic mice: a model of Huntington disease","volume":"4","author":"Perluigi","year":"2005","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.bbadis.2010.05.001_bib23","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/cne.20680","article-title":"Chronology of behavioral symptoms and neuropathological sequela in R6\/2 Huntington's disease transgenic mice","volume":"490","author":"Stack","year":"2005","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.bbadis.2010.05.001_bib24","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","article-title":"Neuropathological classification of Huntington's disease","volume":"44","author":"Vonsattel","year":"1985","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.bbadis.2010.05.001_bib25","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/cne.10776","article-title":"Time course of early motor and neuropathological anomalies in a knock-in mouse model of Huntington's disease with 140 CAG repeats","volume":"465","author":"Menalled","year":"2003","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.bbadis.2010.05.001_bib26","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/978-1-4020-6486-9_4","article-title":"Expression and function of AGAT, GAMT and CT1 in the mammalian brain","volume":"46","author":"Braissant","year":"2007","journal-title":"Subcell Biochem"},{"key":"10.1016\/j.bbadis.2010.05.001_bib27","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/978-1-4020-6486-9_8","article-title":"Cerebral creatine deficiency syndromes: clinical aspects, treatment and pathophysiology","volume":"46","author":"Stockler","year":"2007","journal-title":"Subcell Biochem"},{"key":"10.1016\/j.bbadis.2010.05.001_bib28","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.nbd.2009.10.022","article-title":"Dissociation of AGAT, GAMT and SLC6A8 in CNS: relevance to creatine deficiency syndromes","volume":"37","author":"Braissant","year":"2010","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.bbadis.2010.05.001_bib29","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1146\/annurev.bi.54.070185.004151","article-title":"The creatine\u2013creatine phosphate energy shuttle","volume":"54","author":"Bessman","year":"1985","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.bbadis.2010.05.001_bib30","doi-asserted-by":"crossref","first-page":"C365","DOI":"10.1152\/ajpcell.1984.246.5.C365","article-title":"A simple analysis of the \u201cphosphocreatine shuttle\u201d","volume":"246","author":"Meyer","year":"1984","journal-title":"Am J Physiol"},{"key":"10.1016\/j.bbadis.2010.05.001_bib31","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0092-8674(85)90085-6","article-title":"Metabolite channeling: a phosphorylcreatine shuttle to mediate high energy phosphate transport between sperm mitochondrion and tail","volume":"41","author":"Tombes","year":"1985","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2010.05.001_bib32","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/jcp.1041160214","article-title":"Isozymes of creatine kinase in mammalian cell cultures","volume":"116","author":"Van Brussel","year":"1983","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.bbadis.2010.05.001_bib33","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.bbr.2004.07.002","article-title":"Structural and behavioural consequences of double deficiency for creatine kinases BCK and UbCKmit","volume":"157","author":"Streijger","year":"2005","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.bbadis.2010.05.001_bib34","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1111\/j.1471-4159.2004.02599.x","article-title":"Cerebral creatine kinase deficiency influences metabolite levels and morphology in the mouse brain: a quantitative in vivo 1H and 31P magnetic resonance study","volume":"90","author":"in 't Zandt","year":"2004","journal-title":"J Neurochem"},{"key":"10.1016\/j.bbadis.2010.05.001_bib35","series-title":"Movement disorders: neurological principles and practice","first-page":"603","article-title":"Neuropathology and pathophysiology of Huntington's disease","author":"Hersch","year":"2004"},{"key":"10.1016\/j.bbadis.2010.05.001_bib36","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.bbadis.2009.07.012","article-title":"Mitochondria in Huntington's disease","volume":"1802","author":"Damiano","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.bbadis.2010.05.001_bib37","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1097\/01.wco.0000186842.51129.cb","article-title":"Biomarkers for neurodegenerative diseases","volume":"18","author":"Henley","year":"2005","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.bbadis.2010.05.001_bib38","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1212\/01.wnl.0000194318.74946.b6","article-title":"Creatine in Huntington disease is safe, tolerable, bioavailable in brain and reduces serum 8OH2'dG","volume":"66","author":"Hersch","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2010.05.001_bib39","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.bbadis.2006.03.004","article-title":"Dose ranging and efficacy study of high-dose coenzyme Q10 formulations in Huntington's disease mice","volume":"1762","author":"Smith","year":"2006","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.bbadis.2010.05.001_bib40","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1046\/j.1471-4159.2001.00689.x","article-title":"Increased oxidative damage to DNA in a transgenic mouse model of Huntington's disease","volume":"79","author":"Bogdanov","year":"2001","journal-title":"J Neurochem"},{"key":"10.1016\/j.bbadis.2010.05.001_bib41","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1046\/j.1471-4159.1997.69052064.x","article-title":"Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis","volume":"69","author":"Ferrante","year":"1997","journal-title":"J Neurochem"},{"key":"10.1016\/j.bbadis.2010.05.001_bib42","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1093\/brain\/awm304","article-title":"Metabolomic profiling to develop blood biomarkers for Parkinson's disease","volume":"131","author":"Bogdanov","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.bbadis.2010.05.001_bib43","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/S0891-5849(00)00349-X","article-title":"Increased oxidative damage to DNA in ALS patients","volume":"29","author":"Bogdanov","year":"2000","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.bbadis.2010.05.001_bib44","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1080\/10715760400027979","article-title":"Increased oxidative damage to DNA in an animal model of amyotrophic lateral sclerosis","volume":"39","author":"Aguirre","year":"2005","journal-title":"Free Radic Res"},{"key":"10.1016\/j.bbadis.2010.05.001_bib45","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00415-009-5333-x","article-title":"Levels of reduced and oxidized coenzyme Q-10 and 8-hydroxy-2'-deoxyguanosine in the CSF of patients with Alzheimer's disease demonstrate that mitochondrial oxidative damage and\/or oxidative DNA damage contributes to the neurodegenerative process","volume":"257","author":"Isobe","year":"2010","journal-title":"J Neurol"},{"key":"10.1016\/j.bbadis.2010.05.001_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2008.06.005","article-title":"Rodent genetic models of Huntington disease","volume":"32","author":"Heng","year":"2008","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.bbadis.2010.05.001_bib47","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1602\/neurorx.1.3.298","article-title":"Translating therapies for Huntington's disease from genetic animal models to clinical trials","volume":"1","author":"Hersch","year":"2004","journal-title":"NeuroRx"},{"key":"10.1016\/j.bbadis.2010.05.001_bib48","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/978-1-4020-6486-9_16","article-title":"Creatine and creatine kinase in health and disease\u2014a bright future ahead?","volume":"46","author":"Wyss","year":"2007","journal-title":"Subcell Biochem"},{"key":"10.1016\/j.bbadis.2010.05.001_bib49","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0014-5793(97)01045-4","article-title":"The role of creatine kinase in inhibition of mitochondrial permeability transition","volume":"414","author":"O'Gorman","year":"1997","journal-title":"FEBS Lett"},{"key":"10.1016\/j.bbadis.2010.05.001_bib50","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/978-1-4020-6486-9_11","article-title":"The neuroprotective role of creatine","volume":"46","author":"Klein","year":"2007","journal-title":"Subcell Biochem"},{"key":"10.1016\/j.bbadis.2010.05.001_bib51","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1046\/j.1471-4159.2001.00052.x","article-title":"On the mechanisms of neuroprotection by creatine and phosphocreatine","volume":"76","author":"Brustovetsky","year":"2001","journal-title":"J Neurochem"},{"key":"10.1016\/j.bbadis.2010.05.001_bib52","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.nbd.2003.12.014","article-title":"Neuroprotective mechanisms of creatine occur in the absence of mitochondrial creatine kinase","volume":"15","author":"Klivenyi","year":"2004","journal-title":"Neurobiol Dis"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092544391000089X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092544391000089X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T23:22:36Z","timestamp":1559085756000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092544391000089X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":52,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["S092544391000089X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2010.05.001","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7]]}}}